Australia's largest stock trading and investment forum Australia's #1 stock forum

So theres a spurt of news, including a key trial completed and...

First 1241 Last

Share
Profile

Follow
Rajenp5

2,407 Posts.

19

29/06/24

03:21

Post #: 74529112
Share

Originally posted by Alf107: ↑

I will throw a number out there.
So assuming the following points are in place...yes big assumption.

1. The STS trials are successful,
2. The report from the stage 1 H&NC trials is positive
3. The human wound healing Phase 1 trials in Australia is a success
4. The Stelfonta sales have increased to originally forecast (something that will never be revealed)

The market cap should be approx. $1.2 - $1.8B market cap.
Share price of $2.50 - $3.70 in 6 months time.
I have nothing to support this number but MC is generally 3 - 5 times of generated revenue.
If STS and H&NC get to FDA approvals in 3-4 years time and is able to capture 10% - 15% of this available market, the MC could grow to 3 - 4 times.

Expand

So theres a spurt of news, including a key trial completed and the latest sales are downward?

Last edited by Rajenp5: 29/06/24
Upvote

Reply

Top Stories

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

What's causing the cost-of-living crisis, and how to navigate it

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

There are more pages in this discussion • 75 more messages in this thread...

First 1241 Last